Literature DB >> 27778056

[Unilateral spinal anesthesia : Literature review and recommendations].

B Büttner1, A Mansur2, M Bauer3, J Hinz3, I Bergmann3.   

Abstract

Unilateral spinal anesthesia is a cost-effective and rapidly performed anesthetic technique. An exclusively unilateral block only affects the sensory, motor and sympathetic functions on one side of the body and offers the advantages of a spinal block without the typical adverse side effects seen with a bilateral block. The lack of hypotension, in particular, makes unilateral spinal anesthesia suitable for patients with cardiovascular risk factors e. g. aortic valve stenosis or coronary artery disease. Increasing numbers of surgical procedures are now being performed on an outpatient basis. Until now, spinal anesthesia has been considered unsuitable for this, not only because of the high incidence of intraoperative hypotension and postoperative urinary retention but also because of the prolonged postoperative stay before home discharge. This is not the case with unilateral spinal anesthesia: motor function returns rapidly, the incidence of urinary retention is extremely low, and patients are usually eligible for home discharge sooner than after bilateral spinal anesthesia or general anesthesia. The success of the technique depends on a number of factors. In addition to the local anesthetic, its concentration and dose, and the baricity of the injected solution, the shape of the spinal needle, the injection speed, the patient's position during injection, and the time the patient remains in this position after injection are equally important parameters. A number of intrathecally applied adjuvant drugs are used to give a more intense and/or longer-lasting block. For this review, we collated the published data on unilateral spinal anesthesia from journals with an impact factor greater than 1.0 and defined an optimized method for performing the technique. In order to achieve an exclusively unilateral block one should use 0.5 % hyperbaric bupivacaine injected at a rate of 0.33 ml/min or slower. During the injection and the following 20 min the patient should lie in the lateral decubitus position on the side intended for surgery with knees drawn to the chest. An injection of 5 mg (1 ml) hyperbaric bupivacaine 0.5 % provides an hour-long block to T 12, and a dose of 7.5 to 10 mg (1.5-2.0 ml) extends the block to T 6. Adding clonidine (0.5 to 1.0 µg/kg BW) to the injection prolongs the duration of the block to approximately two to three hours. During the 20-minute fixation period, the cephalad spread of the block can be influenced to a certain extent by raising or lowering the head of the table.

Entities:  

Keywords:  Hemodynamics; Injection speed; Local anesthetic; Sympathetic block; Unilateral spinal anesthesia

Mesh:

Substances:

Year:  2016        PMID: 27778056     DOI: 10.1007/s00101-016-0232-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  131 in total

1.  Use of small-dose bupivacaine (3 mg vs 4 mg) for unilateral spinal anesthesia in the outpatient setting.

Authors:  Shashi Kiran; Bhatia Upma
Journal:  Anesth Analg       Date:  2004-07       Impact factor: 5.108

Review 2.  [Levobupivacaine for regional anesthesia. A systematic review].

Authors:  B Urbanek; S Kapral
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

3.  An analysis of the safety of epidural and spinal neuraxial anesthesia in more than 100,000 consecutive major lower extremity joint replacements.

Authors:  Matthias Pumberger; Stavros G Memtsoudis; Ottokar Stundner; Richard Herzog; Friedrich Boettner; Elizabeth Gausden; Alexander P Hughes
Journal:  Reg Anesth Pain Med       Date:  2013 Nov-Dec       Impact factor: 6.288

4.  Relation of electrical properties of skin to structure and physiologic state.

Authors:  R Edelberg
Journal:  J Invest Dermatol       Date:  1977-09       Impact factor: 8.551

5.  Time-courses of zones of differential sensory blockade during spinal anesthesia with hyperbaric tetracaine or bupivacaine.

Authors:  S J Brull; N M Greene
Journal:  Anesth Analg       Date:  1989-09       Impact factor: 5.108

6.  Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine.

Authors:  M Schneider; T Ettlin; M Kaufmann; P Schumacher; A Urwyler; K Hampl; A von Hochstetter
Journal:  Anesth Analg       Date:  1993-05       Impact factor: 5.108

7.  Success rate of unilateral spinal anesthesia is dependent on injection flow.

Authors:  D Enk; T Prien; H Van Aken; N Mertes; J Meyer; T Brüssel
Journal:  Reg Anesth Pain Med       Date:  2001 Sep-Oct       Impact factor: 6.288

8.  Comparison of ropivacaine 0.5% (in glucose 5%) with bupivacaine 0.5% (in glucose 8%) for spinal anaesthesia for elective surgery.

Authors:  J B Whiteside; D Burke; J A W Wildsmith
Journal:  Br J Anaesth       Date:  2003-03       Impact factor: 9.166

Review 9.  [Post-dural puncture headache].

Authors:  K Radke; O C Radke
Journal:  Anaesthesist       Date:  2013-02       Impact factor: 1.041

Review 10.  Short-acting spinal anesthesia in the ambulatory setting.

Authors:  Johannes G Förster
Journal:  Curr Opin Anaesthesiol       Date:  2014-12       Impact factor: 2.706

View more
  2 in total

1.  Comparison of Efficacy and Safety of Unilateral Spinal Anaesthesia with Sequential Combined Spinal Epidural Anaesthesia for Lower Limb Orthopaedic Surgery.

Authors:  Jyoti Sandeep Magar; Kishori Dhaku Bawdane; Rahul Patil
Journal:  J Clin Diagn Res       Date:  2017-07-01

2.  Determination of the median effective dose (ED50) of bupivacaine and ropivacaine unilateral spinal anesthesia : Prospective, double blinded, randomized dose-response trial.

Authors:  WeiBing Wang; YuanHai Li; AiJiao Sun; HongPing Yu; JingChun Dong; Huang Xu
Journal:  Anaesthesist       Date:  2017-12       Impact factor: 1.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.